{"id":871683,"date":"2025-08-06T10:52:10","date_gmt":"2025-08-06T14:52:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/"},"modified":"2025-08-06T10:52:10","modified_gmt":"2025-08-06T14:52:10","slug":"icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/","title":{"rendered":"IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n CAESAREA, Israel<\/span>
\n <\/span>, Aug. 6, 2025<\/span><\/span> \/PRNewswire\/ — IceCure Medical Ltd.<\/a> (NASDAQ: ICCM) (“IceCure”, “IceCure Medical” or the “Company”), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced \u00a0it will issue a press release with its financial and operational results as of and for the six months ended June 30, 2025<\/span> before the Nasdaq Stock Market opens on Wednesday, August 13, 2025<\/span>. The Company will also discuss such results and other corporate developments on a conference call at 11:00 a.m. EDT<\/span> on the same day.<\/p>\n

\n \"IceCure\n <\/div>\n

\n Conference call & webcast info:
<\/b>
\n Wednesday, August 13, 2025<\/span>, at 11:00 am EDT<\/span>
US: 1-888-407-2553
Israel<\/span>\/International: +972-3-918-0696
A live webcast will be available at: https:\/\/www.veidan-conferenceing.com\/icecure<\/a>
A recording of the webcast will be available at: ir.icecure-medical.com\/<\/a><\/p>\n

\n About IceCure Medical
<\/b>IceCure Medical (NASDAQ: ICCM) develops and markets advanced liquid-nitrogen-based cryoablation therapy systems for the destruction of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally invasive technology is a safe and effective alternative to hospital surgical tumor removal that is easily performed in a relatively short procedure. The Company’s flagship ProSense\u00ae system is marketed and sold worldwide for the indications cleared and approved to date including in the U.S., Europe<\/span> and Asia<\/span>.<\/p>\n

\n Forward Looking Statements<\/b>
\n
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example,\u00a0IceCure\u00a0is using forward looking statements in this press release when it discusses: its expected announcement of financial and operational results as of and for the six months ended June 30, 2025<\/span> and hosting a conference call related to such results\u00a0. Historical results of scientific research and clinical and preclinical trials do not guarantee that the conclusions of future research or trials will suggest identical or even similar conclusions. Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements include, among others: the Company’s planned level of revenues and capital expenditures; the Company’s available cash and its ability to obtain additional funding; the Company’s ability to market and sell its products; legal and regulatory developments in\u00a0the United States\u00a0and other countries; the Company’s ability to maintain its relationships with suppliers, distributors and other partners; the Company’s ability to maintain or protect the validity of its patents and other intellectual property; the Company’s ability to expose and educate medical professionals about its products; political, economic and military instability in the\u00a0Middle East, specifically in\u00a0Israel; as well as those factors set forth in the Risk Factors section of the Company’s Annual Report on Form 20-F for the year ended\u00a0December 31, 2024\u00a0filed with the SEC on\u00a0March 27, 2025, and other documents filed with or furnished to the SEC which are available on the SEC’s website,\u00a0www.sec.gov<\/a>. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.<\/p>\n

\n IR Contact:<\/b>\n <\/p>\n

Email: investors@icecure-medical.com<\/a><\/p>\n

\n Michael Polyviou<\/span>\n <\/p>\n

Phone: 732-232-6914<\/p>\n

Logo – https:\/\/mma.prnewswire.com\/media\/2319310\/IceCure_Medical_Logo.jpg<\/a><\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025-302523052.html<\/a><\/p>\n

SOURCE IceCure Medical<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire CAESAREA, Israel , Aug. 6, 2025 \/PRNewswire\/ — IceCure Medical Ltd. (NASDAQ: ICCM) (“IceCure”, “IceCure Medical” or the “Company”), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced \u00a0it will issue a press release with its financial and operational results as of and for the six months ended June 30, 2025 before the Nasdaq Stock Market opens on Wednesday, August 13, 2025. The Company will also discuss such results and other corporate developments on a conference call at 11:00 a.m. EDT on the same day. Conference call & webcast info: Wednesday, August 13, 2025, at 11:00 am EDTUS: 1-888-407-2553Israel\/International: +972-3-918-0696A live webcast will be available at: https:\/\/www.veidan-conferenceing.com\/icecureA recording … <\/p>\n

Continue reading “IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-871683","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nIceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire CAESAREA, Israel , Aug. 6, 2025 \/PRNewswire\/ — IceCure Medical Ltd. (NASDAQ: ICCM) (“IceCure”, “IceCure Medical” or the “Company”), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced \u00a0it will issue a press release with its financial and operational results as of and for the six months ended June 30, 2025 before the Nasdaq Stock Market opens on Wednesday, August 13, 2025. The Company will also discuss such results and other corporate developments on a conference call at 11:00 a.m. EDT on the same day. Conference call & webcast info: Wednesday, August 13, 2025, at 11:00 am EDTUS: 1-888-407-2553Israel\/International: +972-3-918-0696A live webcast will be available at: https:\/\/www.veidan-conferenceing.com\/icecureA recording … Continue reading "IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-06T14:52:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2319310\/IceCure_Medical_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025\",\"datePublished\":\"2025-08-06T14:52:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\\\/\"},\"wordCount\":584,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2319310\\\/IceCure_Medical_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\\\/\",\"name\":\"IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2319310\\\/IceCure_Medical_Logo.jpg\",\"datePublished\":\"2025-08-06T14:52:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2319310\\\/IceCure_Medical_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2319310\\\/IceCure_Medical_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/","og_locale":"en_US","og_type":"article","og_title":"IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025 - Market Newsdesk","og_description":"PR Newswire CAESAREA, Israel , Aug. 6, 2025 \/PRNewswire\/ — IceCure Medical Ltd. (NASDAQ: ICCM) (“IceCure”, “IceCure Medical” or the “Company”), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced \u00a0it will issue a press release with its financial and operational results as of and for the six months ended June 30, 2025 before the Nasdaq Stock Market opens on Wednesday, August 13, 2025. The Company will also discuss such results and other corporate developments on a conference call at 11:00 a.m. EDT on the same day. Conference call & webcast info: Wednesday, August 13, 2025, at 11:00 am EDTUS: 1-888-407-2553Israel\/International: +972-3-918-0696A live webcast will be available at: https:\/\/www.veidan-conferenceing.com\/icecureA recording … Continue reading \"IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-06T14:52:10+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2319310\/IceCure_Medical_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025","datePublished":"2025-08-06T14:52:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/"},"wordCount":584,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2319310\/IceCure_Medical_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/","name":"IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2319310\/IceCure_Medical_Logo.jpg","datePublished":"2025-08-06T14:52:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2319310\/IceCure_Medical_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2319310\/IceCure_Medical_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icecure-to-report-first-half-2025-financial-and-operating-results-on-august-13-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IceCure to Report First Half 2025 Financial and Operating Results on August 13, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/871683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=871683"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/871683\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=871683"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=871683"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=871683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}